PROM1 and head and neck squamous cell carcinoma: Pre-treatment of HNSCC CD133+ UMSCC-11B cells with dCD133KDEL significantly reduced tumorigenicity in xenotransplantation mouse models, suggesting eradication of the aggressive CD133+ CSC population [271].